A. Sinclair Dunlop
CIK 1721108 · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
46
Lifetime Open-Market Net
-$28.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Director | 0 | $41.03 | $0 | -$28.11M | 46 | 2026-05-14 |
Recent Filings · Page 2 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +1,500 | $19.8K | EDGAR |
| 2024-03-20 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −18,681 | -$1.07M | EDGAR |
| 2024-01-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +3,341 | $0 | EDGAR |
| 2023-12-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +6,274 | $82.8K | EDGAR |
| 2023-12-05 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −24,000 | -$1.47M | EDGAR |
| 2023-11-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −8,894 | -$444.6K | EDGAR |
| 2023-11-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −24,000 | -$1.18M | EDGAR |
| 2023-04-05 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −500 | -$37.0K | EDGAR |
| 2023-03-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −500 | -$32.7K | EDGAR |
| 2023-02-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −500 | -$26.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.